Report cover image

Bio-Rad Laboratories Inc (BIO) - Product Pipeline Analysis, 2024 Update

Publisher GlobalData
Published May 31, 2024
Length 45 Pages
SKU # GBDT18861589

Description

Bio-Rad Laboratories Inc (BIO) - Product Pipeline Analysis, 2024 Update


Summary

Bio-Rad Laboratories Inc (Bio-Rad) manufactures and distributes life science research and clinical diagnostics products. The company's product portfolio includes antibodies, autoimmune testing kits, blood typing and antibody detection systems, cell isolation and analysis tools, and digital PCR, among others. The company serves to various markets including life science research, healthcare, analytical chemistry, and other markets. Bio-Rad’s products find applications in bioprocess analytics, cell research, gene expression analysis, immunology, and mutation detection, among others. It markets products through a direct sales force and a network of distributors, agents, brokers, and resellers worldwide. The company operates in the US, Canada, Latin America, Europe and Asia, among others. Bio-Rad Laboratories Inc is headquartered in Hercules, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Bio-Rad Laboratories Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

45 Pages
Bio-Rad Laboratories Inc Company Overview
Bio-Rad Laboratories Inc Company Snapshot
Bio-Rad Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
Bio-Rad Laboratories Inc – Pipeline Analysis Overview
Business Description
Bio-Rad Laboratories Inc - Key Facts
Bio-Rad Laboratories Inc - Major Products and Services
Bio-Rad Laboratories Inc Pipeline Products by Development Stage
Bio-Rad Laboratories Inc Pipeline Products Overview
Biomeprint
Biomeprint Product Overview
BioPlex 2200 - Gastrointestinal Disease Test
BioPlex 2200 - Gastrointestinal Disease Test Product Overview
BioPlex 2200 - Hepatitis Test
BioPlex 2200 - Hepatitis Test Product Overview
Droplet Digital PCR - MRSA Infection
Droplet Digital PCR - MRSA Infection Product Overview
Gene Based Blood Test - Melanoma
Gene Based Blood Test - Melanoma Product Overview
Genetic Panel - SCD
Genetic Panel - SCD Product Overview
Imaging-And-Microfluidics Chip
Imaging-And-Microfluidics Chip Product Overview
Multiplexed Mutation Detection Assay - Cancer Monitoring
Multiplexed Mutation Detection Assay - Cancer Monitoring Product Overview
Multiplexed Mutation Detection Assay - Therapy Selection
Multiplexed Mutation Detection Assay - Therapy Selection Product Overview
PCR|ONE - Respiratory Panel
PCR|ONE - Respiratory Panel Product Overview
PCR|ONE - STI Panel
PCR|ONE - STI Panel Product Overview
PCR|ONE System
PCR|ONE System Product Overview
PCR|ONE System - Clostridium Panel
PCR|ONE System - Clostridium Panel Product Overview
PCR|ONE System - SARS-CoV-2 Panel
PCR|ONE System - SARS-CoV-2 Panel Product Overview
QX Continuum Droplet Digital PCR System
QX Continuum Droplet Digital PCR System Product Overview
Bio-Rad Laboratories Inc - Key Competitors
Bio-Rad Laboratories Inc - Key Employees
Bio-Rad Laboratories Inc - Key Employee Biographies
Bio-Rad Laboratories Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Bio-Rad Laboratories Inc, Recent Developments
May 22, 2024: GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services
Apr 11, 2024: Bio-Rad and Allegheny Health Network Cancer Institute Partner to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR
Apr 03, 2024: Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
Apr 01, 2024: Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
Mar 26, 2024: Bio-Rad Launches Celselect Slides Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
Feb 27, 2024: Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for Cell and Gene Therapy Production
Jan 02, 2024: Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
Oct 05, 2023: Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
Sep 28, 2023: Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers
Aug 29, 2023: Bio-Rad Launches First StarBright Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Bio-Rad Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Bio-Rad Laboratories Inc Pipeline Products by Equipment Type
Table 3: Bio-Rad Laboratories Inc Pipeline Products by Indication
Table 4: Bio-Rad Laboratories Inc, Key Facts
Table 5: Bio-Rad Laboratories Inc, Major Products and Services
Table 6: Bio-Rad Laboratories Inc Number of Pipeline Products by Development Stage
Table 7: Bio-Rad Laboratories Inc Pipeline Products Summary by Development Stage
Table 8: Biomeprint - Product Status
Table 9: Biomeprint - Product Description
Table 10: BioPlex 2200 - Gastrointestinal Disease Test - Product Status
Table 11: BioPlex 2200 - Gastrointestinal Disease Test - Product Description
Table 12: BioPlex 2200 - Hepatitis Test - Product Status
Table 13: BioPlex 2200 - Hepatitis Test - Product Description
Table 14: Droplet Digital PCR - MRSA Infection - Product Status
Table 15: Droplet Digital PCR - MRSA Infection - Product Description
Table 16: Gene Based Blood Test - Melanoma - Product Status
Table 17: Gene Based Blood Test - Melanoma - Product Description
Table 18: Genetic Panel - SCD - Product Status
Table 19: Genetic Panel - SCD - Product Description
Table 20: Imaging-And-Microfluidics Chip - Product Status
Table 21: Imaging-And-Microfluidics Chip - Product Description
Table 22: Multiplexed Mutation Detection Assay - Cancer Monitoring - Product Status
Table 23: Multiplexed Mutation Detection Assay - Cancer Monitoring - Product Description
Table 24: Multiplexed Mutation Detection Assay - Therapy Selection - Product Status
Table 25: Multiplexed Mutation Detection Assay - Therapy Selection - Product Description
Table 26: PCR|ONE - Respiratory Panel - Product Status
Table 27: PCR|ONE - Respiratory Panel - Product Description
Table 28: PCR|ONE - STI Panel - Product Status
Table 29: PCR|ONE - STI Panel - Product Description
Table 30: PCR|ONE System - Product Status
Table 31: PCR|ONE System - Product Description
Table 32: PCR|ONE System - Clostridium Panel - Product Status
Table 33: PCR|ONE System - Clostridium Panel - Product Description
Table 34: PCR|ONE System - SARS-CoV-2 Panel - Product Status
Table 35: PCR|ONE System - SARS-CoV-2 Panel - Product Description
Table 36: QX Continuum Droplet Digital PCR System - Product Status
Table 37: QX Continuum Droplet Digital PCR System - Product Description
Table 38: Bio-Rad Laboratories Inc, Key Employees
Table 39: Bio-Rad Laboratories Inc, Key Employee Biographies
Table 40: Bio-Rad Laboratories Inc, Subsidiaries
Table 41: Glossary
List of Figures
Figure 1: Bio-Rad Laboratories Inc Pipeline Products by Equipment Type
Figure 2: Bio-Rad Laboratories Inc Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us